Intech Investment Management 13F: Cuts CL Stake by $10M
Intech Investment Management reduced its Colgate-Palmolive position by nearly 29%, reflecting in its recent 13F filing.
Reviewed by automated data checks against the source filing. How we make and check alerts
Intech Investment Management sold 113,364 shares from its stake in Colgate-Palmolive Company ($CL), a 28.92% decrease, according to a 13F filing with the SEC dated May 8, 2026. It reported 278,568 shares worth $25.54 million at the end of the quarter.
Since the filing, $CL is up 0.7% after 1 week, down 1.7% after 1 month and up 8.1% to date (from the $87.05 close on May 8, 2026).
Find the original: Intech Investment Management 13F filings on SEC EDGAR
CL
Colgate-Palmolive Company
Key Points
- Intech Investment Management cut its stake in Colgate-Palmolive by 113,364 shares, reducing its position by 28.9% to 278,568 shares.
- Colgate-Palmolive shares trade near $89.45 with a market cap of about $71.6 billion and a forward P/E of 22.1.
- Insiders at Colgate-Palmolive, including EVP Malcolm Gregory, engaged in recent stock transactions, with analysts maintaining a positive outlook.
Get $CL trade alerts by text
We text you when insiders, Congress or big funds trade $CL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Colgate-Palmolive Company alert may contain errors. Disclosures
Intech Investment Management recently filed a 13F with the SEC, revealing a significant reduction in its holdings of Colgate-Palmolive Company (NYSE: CL). The firm cut its stake by 113,364 shares, a 28.9% decrease, leaving it with 278,568 shares valued at approximately $24.9 million as of the filing date.
What Changed in Intech Investment Management's Colgate-Palmolive Position
Intech Investment Management decided to reduce its investment in Colgate-Palmolive, moving from 391,932 shares to 278,568 shares. This reduction of 113,364 shares represents a 28.9% decrease in their position. The remaining shares are valued at about $24.9 million.
Other Institutional Activity in Colgate-Palmolive
Other major funds have also adjusted their positions in Colgate-Palmolive. BlackRock, Inc. increased its holdings by 2,171,094 shares, bringing its total to 72,643,002 shares valued at around $6.19 billion. Price T Rowe Associates Inc /MD/ added 2,541,888 shares, ending with 33,729,165 shares worth $2.87 billion. Meanwhile, State Street Corp reduced its stake by 755,303 shares, holding 47,719,482 shares valued at approximately $4.07 billion. Geode Capital Management, LLC grew its position by 796,389 shares, totaling 22,900,290 shares worth $1.97 billion.
Colgate-Palmolive Company Stock Down 1.2%
Shares of Colgate-Palmolive (NYSE: CL) are trading around $89.45. The company has a market capitalization of approximately $71.6 billion. It holds a P/E ratio of 34.7 and a forward P/E of 22.1, with a beta of 0.322, indicating lower volatility compared to the market. The stock's 52-week range is between $74.55 and $99.33, with a 50-day moving average of $86.78 and a 200-day moving average of $84.28.
Recent Earnings
Colgate-Palmolive reported revenue of $20.8 billion, reflecting a growth rate of 8.4%. The net margin stands at 10%, while the return on equity is 3.6%. The company is scheduled to announce its next earnings on July 31, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
4 analysts raised price targets.
-
EPS & revenue
EPS met estimates. Revenue missed estimates by 0.9%.
-
Profit surprise
EBITDA missed by 15 percent. Operating income missed by 17 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
4 target raises.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Colgate delivered a solid first quarter with accelerating volume growth, especially in emerging markets and the Hill's pet food business, which grew nearly 5 percent. However, North America oral care remains weak and the company faces significant pressure from rising costs in resins, petrochemicals, and oils, which are expected to be up more than 20 percent year over year. Management is confident in its ability to maintain earnings growth through pricing, innovation, and efficiency programs while continuing to invest in brands.
Guidance The company reaffirmed full year earnings growth in the low to mid single digits. They expect gross margins to decline due to about $300 million in additional raw material and logistics costs tied to oil prices around $110 per barrel. They plan to offset inflation through revenue growth management, innovation, and a $200 million to $300 million cost savings program.
Fine but not compelling. Acceptable results that likely do not create a meaningful forward reset.
Dividend
Colgate-Palmolive offers an annual dividend rate of $2.12, yielding 2.37% based on its current stock price. The dividend payout ratio is 80.6%.
Insider Buying and Selling at Colgate-Palmolive Company
Recent insider transactions at Colgate-Palmolive include EVP and Controller Malcolm Gregory selling 2,300 shares at an average price of $88.44 on May 15, 2026. On May 11, 2026, several insiders, including Lisa Edwards, Kimberly Nelson, Brian Newman, and John Cahill, purchased shares, though the transaction prices were not disclosed.
Analysts Set New Price Targets
Several analysts have updated their ratings and price targets for Colgate-Palmolive. On June 12, 2026, Bernstein initiated coverage with a 'hold' rating and a $96 target. Barclays maintained its 'hold' rating with an $80 target on May 5, 2026. JP Morgan and UBS both reiterated their 'buy' ratings with targets of $96 and $100, respectively, on May 4, 2026. The consensus recommendation for Colgate-Palmolive is 'buy', with an average target price of $95.85 based on 20 analyst opinions.
About Colgate-Palmolive
Colgate-Palmolive Company, based in New York, is a leading consumer goods firm operating in the Consumer Defensive sector. It manufactures and sells a range of household and personal products, including oral care items, soaps, and pet nutrition products. With a history dating back to 1806, the company markets its products under well-known brands such as Colgate, Palmolive, and Hill's Science Diet. Led by CEO Noel R. Wallace, Colgate-Palmolive employs about 33,600 people worldwide.
Bottom Line
Intech Investment Management's recent 13F filing shows a significant reduction in its stake in Colgate-Palmolive, reflecting changes in its investment strategy. Investors will keep a close eye on Colgate-Palmolive's performance, particularly with its upcoming earnings report on July 31, 2026. The company's strong market position and analyst support continue to make it a focal point for institutional and individual investors alike.
Related Filing Alerts
Source: Intech Investment Management's 13F filing on $CL (May 8, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Intech Investment Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts